Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004956-35Phase 4Terminated
Phase 4, open-label, single-arm trial of human insulin in chronic obstructive pulmonary disease (COPD) and Stress Hyperglycemia (SH), sponsored by St George's, University of London. Primary endpoint: Severe hypoglycaemia. Started Nov 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004956-35.